Wall Street Analysts See a 219.98% Upside in Syndax (SNDX): Can the Stock Really Move This High?

Syndax Pharmaceuticals (SNDX) closed the last trading session at $11.01, gaining 4.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 35.23 indicates a 220% upside potential.The mean estimate comprises 13 short-term price targets with a standard deviation of $10.34. While the lowest estimate of$ 17 indicates a 54.4% increase from the current price level, the most optimistic analys ...